Arcturus Therapeutics Ltd (NASDAQ:ARCT)

5.15
Delayed Data
As of 12:23pm ET
 -0.05 / -0.96%
Today’s Change
4.78
Today|||52-Week Range
15.19
-35.22%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Arcturus Therapeutics Ltd have a median target of 12.00, with a high estimate of 12.00 and a low estimate of 12.00. The median estimate represents a +133.01% increase from the last price of 5.15.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Arcturus Therapeutics Ltd. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.47
Sales
$0.00
Reporting Date
May 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -2.17%
 
 
 
 
 
 
Growthannually -167.28%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.